Alzheimer's disease (AD) is a common neurodegenerative disorder linked to cholinergic dysfunction, with butyrylcholinesterase (BChE) being a key therapeutic target for moderate-severe AD. The gene discussed is BCHE; the disease is Alzheimer disease.